World Health Organization site
Skip Navigation Links

Main
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: REBEC
Last refreshed on: 29 April 2013
Main ID:  RBR-994xfs
Date of registration: 24/11/2011
Primary sponsor: UNESP-Universidade EStadual Paulista Juluo de Mesquita Filho/ Faculdade de Odontologia de Sâo José dos Campos - Brazil
Public title: Effects of specific therapies on the masticatory system and on sleep variables in cerebral palsy patients.
Scientific title: Randomized, five arm clinical trial to evaluate the effects of neuromuscular electrical stimulation, lasertherapy and ledtherapy on the masticatory system and the impact on sleep variables in cerebral palsy patients.
Date of first enrolment: 07/03/2011
Target sample size: 50
Recruitment status: recruiting
URL:  http://www.ensaiosclinicos.gov.br/rg/RBR-994xfs/
Study type: 
Study design:  Clinical trial, five arm, randomized controlled.  
Countries of recruitment
Brazil
Contacts
Name: Luis   Franco de Oliveira
Address:  Av Benedito Matarazzo 12243700 São Paulo Brazil
Telephone: 55 11 91069296
Email: oliveira.lvf@uninove.br
Affiliation:  UNINOVE -Universidade Nove de Julho- São Paulo - SP
Name: Monica  Gomes
Address:  Av Engenheiro Francisco José Longo,777 12200000 São José dos Campos Brazil
Telephone: 55 12 3947 9086
Email: mfgomes@fosjc.br
Affiliation:  UNESP-Universidade EStadual Paulista Juluo de Mesquita Filho/ Faculdade de Odontologia de Sâo José dos Campos
Key inclusion & exclusion criteria
Inclusion criteria: Subjects from both gender, between 7-15 years old with cerebral palsy; present cognitive system partly preserved; sign the consent term.
Exclusion criteria: Have used botulim toxin before 6 month prior the study;have underwent ortodontic treatment prior the study.

Age minimum: 7Y
Age maximum: 15Y
Gender: -
Health Condition(s) or Problem(s) studied
Cerebral palsy.
C10.228.140.140.254
C10.886
Intervention(s)
Polysomnographic exam and electromiographic inicial data will be carry out in all sample. Then, it will be divided in 5 groups with 10 subjects each. Group 1 will be treated with neuromuscular electrical stimulation twice a week, during 8 consecutive weeks; Group 2 will be treated with laser terapy twice a week, during 8 consecutive weeks; Group 3 will be treated with led therapy twice a week, during 8 consecutive weeks; Group 4 will be treated with neuromuscular electrical stimulation and laser therapy twice a week, during 8 consecutive weeksand Group 5 will be treated with neuromuscular electrical stimulation and led therapy twice a week, during 8 consecutive weeks. At the end of each therapy, the polysomnographic and electromiographic data will be colected.
Primary Outcome(s)
To evaluate the effects of LED on the masticatory muscles activity and mandibular opening in cerebral palsy subjects, will be used surface electromiography, power transductor and goniometer.
To evaluate the effects of lower power laser on the masticatory muscles activity and mandibular opening in cerebral palsy subjects, will be used surface electromiography, power tranductor and goniometer.
To evaluate the effects of neuromuscular electrical stimulation on the masticatory muscles activity and mandibular opening in cerebral palsy subjects, will be used surface electromiography, power transductor and goniometer.
To evaluate the effects of neuromuscular electrical stimulation plus laserterapy on the masticatory muscles activity and mandibular opening in cerebral palsy subjects, will be used surface electromiography, power transductor and goniometer.
To evaluate the effects of neuromuscular electrical stimulation plus ledterapy on the masticatory muscles activity and mandibular opening in cerebral palsy subjects, will be used surface electromiography, power transductor and goniometer.
Secondary Outcome(s)
Polysomnograpy will be used to detect and diagnose the sleep breathing disorders, mostly obstructive sleep apnea.
Polysomnograpy will be used to evaluate the oxyhemogloblin dessaturation.
Polysomnograpy will be used to evaluate the sleep architerure status, detecting the balance and / or imbalance between superficial and deep sleep stages.
Secondary ID(s)
007/2011
02495/09-0
Source(s) of Monetary Support
Coordenação de Aperfeiçoamento de Pessoal de Nível Superior-CAPES - Brazil
Secondary Sponsor(s)
UNINOVE -Universidade Nove de Julho- São Paulo - SP - Brazil
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.1 - Version history